Key facts
- It has raised $330K across 1 recorded rounds; the latest was Seed Round ($325K) in Mar 2025.
- Sherpa RX has filed 1 Form D with the SEC, most recently Mar 2025 ($325K sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Sherpa RX
Funding rounds
1 roundsAbout Sherpa RX
Developer of an artificial intelligence-based clinical decision support technology designed to make personalized and precise medicine for patients worldwide. The company's platform provides tools and insights to help healthcare providers manage extensive medical data, make informed decisions, and establish effective treatment plans tailored to the genetic makeup of each patient, enabling clients to navigate the complexities of healthcare with precision and confidence.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2024
- Website
- sherparx.com/
- Ownership
- Privately Held (backing)
Sherpa RX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sherpa RX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sherpa RX in its N-PORT filings yet. We sweep new filings monthly.